Losartan
ARBLI, COZAAR, Losartan Potassium, Losortan Potassium
Angiotensin II Receptor Blocker (ARB)
NADAC/unit
$0.0210
No Shortage
Tier 1: 223.4%
17 Manufacturers
51 ANDAs
Losartan potassium tablets are an angiotensin II receptor blocker (ARB) indicated for: • Treatment of hypertension, to lower blood pressure in adults and children greater than 6 years old.
vs. brand ARBLI: Generic saves up to 100% per unit
Market Intelligence
2023-07-12 Class II Recall: Strides Pharma Inc.
Generic Manufacturers
AIPING PHARMACEUTICAL INCALEMBIC PHARMACEUTICALS LTDAUROBINDO PHARMA LTDCHARTWELL RX SCIENCES LLCGRANULES INDIA LTDGRAVITI PHARMACEUTICALS PRIVATE LTDHETERO LABS LTD UNIT VJUBILANT CADISTA PHARMACEUTICALS INCLUPIN LTDMACLEODS PHARMACEUTICALS LTDMICRO LABS LTDMSN LABORATORIES PRIVATE LTDORGANON LLC A SUB OF ORGANON AND COPRINSTON PHARMACEUTICAL INCSCIENTURE LLCSTRIDES PHARMA GLOBAL PTE LTDUNICHEM LABORATORIES LTDWATSON LABORATORIES INCZYDUS PHARMACEUTICALS USA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.